Publications found:
159,963
Sort by:
Ofatumumab Market, Global Outlook and Forecast 2022-2028
US$ 3,250.00
Ofatumumab is a fully human monoclonal antibody to CD20, which appears to inhibit early-stage B lymphocyte activation. Under the brand name Arzerra, it is approved for the treatment of certain types o...
July 2022
115 pages
PBAT and PBS Market, Global Outlook and Forecast 2022-2028
US$ 3,250.00
This report contains market size and forecasts of PBAT and PBS in global, including the following market information: Global PBAT and PBS Market Revenue, 2017-2022, 2023-2028, ($ millions) Global PBAT...
July 2022
111 pages